We are live on ! Find out more
WST icon

West Pharmaceutical
WST

638 hedge funds and large institutions have $16.9B invested in West Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 246 increasing their positions, 221 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $38.3M | Put options by funds: $18.8M

11% more repeat investments, than reductions

Existing positions increased: 246 | Existing positions reduced: 221

0.82% more ownership

Funds ownership: 91.88% → 92.7% (+0.82%)

3% less funds holding

Funds holding: 655 → 638 (-17)

11% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 83

18% less capital invested

Capital invested by funds: $20.6B → $16.9B (-$3.69B)

30% less funds holding in top 10

Funds holding in top 10: 10 → 7 (-3)

Holders
638
Holders Change
-17
Holders Change %
-2.6%
% of All Funds
10.99%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.12%
New
74
Increased
246
Reduced
221
Closed
83
Calls
$38.3M
Puts
$18.8M
Net Calls
+$19.5M
Net Calls Change
-$4.27M

Top Buyers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
+$153M
2
Brown Advisory
Brown Advisory
Maryland
+$72M
3
DCP
Durable Capital Partners
Maryland
+$56.5M
4
Amundi
Amundi
France
+$42.3M
5
Millennium Management
Millennium Management
New York
+$41.2M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$724M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$88.6M
3
IIM
INTECH Investment Management
Florida
-$56.5M
4
Invesco
Invesco
Georgia
-$56.1M
5
Franklin Resources
Franklin Resources
California
-$35.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
IG
226
ING Group
Netherlands
$2.86M -$711K -2,334 -17%
TRCT
227
Tower Research Capital (TRC)
New York
$2.8M +$174K +570 +5%
GIBU
228
Gulf International Bank (UK)
United Kingdom
$2.73M – – –
II
229
Inspire Investing
Idaho
$2.73M +$613K +2,012 +22%
SG Americas Securities
230
SG Americas Securities
New York
$2.69M +$728K +2,389 +28%
COPPSERS
231
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.67M +$14K +46 +0.4%
SAM
232
Silvercrest Asset Management
New York
$2.65M -$124K -408 -4%
Mackenzie Financial
233
Mackenzie Financial
Ontario, Canada
$2.63M +$141K +464 +5%
Teacher Retirement System of Texas
234
Teacher Retirement System of Texas
Texas
$2.63M -$4.83M -15,869 -60%
MUAMU
235
Mitsubishi UFJ Asset Management (UK)
United Kingdom
$2.58M – – –
TPSF
236
Texas Permanent School Fund
Texas
$2.58M +$211K +693 +7%
BIAS
237
Beacon Investment Advisory Services
New Jersey
$2.56M +$637K +2,092 +25%
AAM
238
Advisors Asset Management
Colorado
$2.55M +$64.3K +211 +2%
MOACM
239
Mutual of America Capital Management
New York
$2.53M +$46.3K +152 +2%
JG
240
Jefferies Group
New York
$2.43M +$3.01M +9,874 New
YIH
241
Y-Intercept (HK)
Hong Kong
$2.42M +$3M +9,843 New
Janus Henderson Group
242
Janus Henderson Group
United Kingdom
$2.41M +$8.84K +29 +0.3%
Walleye Capital
243
Walleye Capital
New York
$2.41M +$2.12M +6,966 +248%
Commonwealth Equity Services
244
Commonwealth Equity Services
Massachusetts
$2.4M +$87.4K +287 +3%
CIBC Asset Management
245
CIBC Asset Management
Ontario, Canada
$2.39M +$224K +736 +8%
Fifth Third Bancorp
246
Fifth Third Bancorp
Ohio
$2.34M +$214K +703 +8%
HighTower Advisors
247
HighTower Advisors
Illinois
$2.31M -$14.6K -48 -0.5%
Los Angeles Capital Management
248
Los Angeles Capital Management
California
$2.29M -$1.13M -3,698 -28%
ACM
249
AlphaCrest Capital Management
New York
$2.26M +$1.27M +4,166 +83%
Swedbank
250
Swedbank
Sweden
$2.26M – – –
8 9
10
11 12

WST Hedge Fund Activity: Q3 2022 in Review

638 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2022, worth a combined $16.9B — down 18% from $20.6B a quarter earlier.

Sellers outnumbered buyers: 83 funds closed out of WST and 74 opened new positions — a net loss of 9 holders — while 221 trimmed existing stakes and 246 added.

The largest buyer was Bank of New York Mellon, adding an estimated $153M. The largest seller was T. Rowe Price Associates, cutting an estimated $724M.

  • 638 institutional investors held West Pharmaceutical (WST) as of Q3 2022, down from 655 in Q2 2022.
  • Funds reported $16.9B of West Pharmaceutical stock for Q3 2022, down 18% quarter-over-quarter.
  • 74 funds opened new West Pharmaceutical positions in Q3 2022 and 83 closed out, a net change of -9 holders.
  • The largest West Pharmaceutical buyer in Q3 2022 was Bank of New York Mellon, an estimated $153M added.
  • The largest West Pharmaceutical seller in Q3 2022 was T. Rowe Price Associates, an estimated $724M sold.

Based on aggregated 13F filings for Q3 2022.